Cargando…

Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms

OBJECTIVE: Accurate preoperative identification of benign or malignant pancreatic cystic neoplasms (PCN) may help clinicians make better intervention choices and will be essential for individualized treatment. METHODS: Preoperative ultrasound and laboratory examination findings, and demographic char...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiuchao, Wang, Junjin, Wei, Xi, Zhao, Lihui, Ni, Bo, Li, Zekun, Gao, Chuntao, Gao, Song, Zhao, Tiansuo, Wang, Jian, Ma, Weidong, Hu, Xiao, Hao, Jihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Compuscript 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630525/ https://www.ncbi.nlm.nih.gov/pubmed/36350006 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0258

Ejemplares similares

An Integrative Pan-Cancer Analysis Revealing MLN4924 (Pevonedistat) as a Potential Therapeutic Agent Targeting Skp2 in YAP-Driven Cancers
por: Lan, Chungen, et al.
Publicado: (2022)

A new combined criterion to better predict malignant lesions in patients with pancreatic cystic neoplasms
por: Lan, Chungen, et al.
Publicado: (2018)

Serum insulin‐like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma‐associated malnutrition and muscle wasting
por: Dong, Jie, et al.
Publicado: (2021)

CypA, a Gene Downstream of HIF-1α, Promotes the Development of PDAC
por: Zhang, Huan, et al.
Publicado: (2014)

Crosstalk Between Peripheral Innervation and Pancreatic Ductal Adenocarcinoma
por: Ni, Bo, et al.
Publicado: (2023)

Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I–III pancreatic ductal adenocarcinoma: a retrospective cohort study
por: Zou, Yiping, et al.
Publicado: (2023)

Comparison of adjuvant nab-paclitaxel plus gemcitabine, S-1 and gemcitabine chemotherapy for resectable pancreatic cancer: a real-world study
por: Li, Haorui, et al.
Publicado: (2023)

SCF, Regulated by HIF-1α, Promotes Pancreatic Ductal Adenocarcinoma Cell Progression
por: Gao, Chuntao, et al.
Publicado: (2015)

ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour–stromal IL-1β/NF–κB/ESE3 signalling axis
por: Zhao, Tiansuo, et al.
Publicado: (2022)

Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes
por: Wang, Xiuchao, et al.
Publicado: (2016)

IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer
por: Zhao, Tiansuo, et al.
Publicado: (2020)

Diagnostic Concordance and Preoperative Risk Factors for Malignancy in Pancreatic Mucinous Cystic Neoplasms
por: Kim, Ga Hee, et al.
Publicado: (2022)

Hypoxia-Inducible Factor-1α Regulates Chemotactic Migration of Pancreatic Ductal Adenocarcinoma Cells through Directly Transactivating the CX3CR1 Gene
por: Zhao, Tiansuo, et al.
Publicado: (2012)

Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma
por: Fu, Danqi, et al.
Publicado: (2023)

Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma
por: Zhao, Tiansuo, et al.
Publicado: (2014)

Correction: Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma
por: Zhao, Tiansuo, et al.
Publicado: (2019)

Molecular analysis of pancreatic cystic neoplasm in routine clinical practice
por: Herranz Pérez, Raquel, et al.
Publicado: (2021)

A prospective study on endoscopic ultrasound for the differential diagnosis of serous cystic neoplasms and mucinous cystic neoplasms
por: Zhong, Lisen, et al.
Publicado: (2019)

Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer
por: Xu, Yu, et al.
Publicado: (2017)

Effect of Perioperative CEA and CA24-2 on Prognosis of Early Resectable Pancreatic Ductal Adenocarcinoma
por: Li, Xiaojie, et al.
Publicado: (2020)

Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma
por: Zhao, Tiansuo, et al.
Publicado: (2015)

Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer
por: Li, Shengnan, et al.
Publicado: (2022)

Multi-Phase CT-Based Radiomics Nomogram for Discrimination Between Pancreatic Serous Cystic Neoplasm From Mucinous Cystic Neoplasm
por: Gao, Jiahao, et al.
Publicado: (2021)

Preoperative differentiation of pancreatic cystic neoplasm subtypes on computed tomography radiomics
por: Zhang, Yifan, et al.
Publicado: (2023)

Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm
por: Cui, Ming, et al.
Publicado: (2023)

Pancreatic Cystic Neoplasms: Predictors of Malignant Behavior and Management
por: Atef, Ehab, et al.
Publicado: (2013)

Serum Carbohydrate Antigen 19-9 in Differential Diagnosis of Benign and Malignant Pancreatic Cystic Neoplasms: A Meta-Analysis
por: Cao, Shaobo, et al.
Publicado: (2016)

Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreas
por: Deng, Shengming, et al.
Publicado: (2020)

A Mucinous Cystic Neoplasm of the Mesocolon Showing Features of Malignancy
por: Mistry, Kiki, et al.
Publicado: (2012)

The value of systemic inflammatory markers in identifying malignancy in mucinous pancreatic cystic neoplasms
por: Zhou, Wentao, et al.
Publicado: (2017)

CT-Based Radiomics Analysis for Preoperative Diagnosis of Pancreatic Mucinous Cystic Neoplasm and Atypical Serous Cystadenomas
por: Xie, Tiansong, et al.
Publicado: (2021)

BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis
por: Huang, Chongbiao, et al.
Publicado: (2023)

Computer-Aided Diagnosis of Pancreas Serous Cystic Neoplasms: A Radiomics Method on Preoperative MDCT Images
por: Wei, Ran, et al.
Publicado: (2019)

Endoscopic ultrasound-guided injective ablative treatment of pancreatic cystic neoplasms
por: Du, Chen, et al.
Publicado: (2020)

Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression
por: Huang, Chongbiao, et al.
Publicado: (2017)

Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma
por: Liu, Jing, et al.
Publicado: (2019)

Overweight Increases the Risk of Malignancy in Patients with Pancreatic Mucinous Cystic Neoplasms
por: Chang, Yu-Ting, et al.
Publicado: (2015)

Online calculator for predicting the risk of malignancy in patients with pancreatic cystic neoplasms: A multicenter, retrospective study
por: Jiang, Dong, et al.
Publicado: (2022)

The Value of Preoperative Alpha-L-Fucosidase Levels in Evaluation of Malignancy and Differential Diagnosis of Urothelial Neoplasms
por: Chen, Dongshan, et al.
Publicado: (2020)

Role of abdominal ultrasound for the surveillance follow-up of pancreatic cystic neoplasms: a cost-effective safe alternative to the routine use of magnetic resonance imaging
por: Morelli, Luca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_svcfut398kpdj9hj85kksf4797